1. Ito, A., Hirai, K., Inoue, M., Koga, H., Susue, S., Irikura, T., Mitsuhashi, S. In vitro antibacterial activity of AM 714, a new nalidixic acid analog. Antimicrob. Agents Chemother. 17 (1980) 103–108.
2. Gadebusch, H. H., Koupal, L. R., Celozzi, E., Shungu, D., Bland, J., Weissberger, B., Pelak, B., Weinberg, E., Huber, J.: Norfloxacin (MK 0366, AM 715), a new orally-absorbed synthetic compound for the treatment of bacterial infections. 12th International Congress of Chemotherapy, Florence 1981, Abstr. 1020.
3. NCCLS Proposed Standard: PSM-7. Standard methods for dilution antimicrobial susceptibility test for bacteria which grow aerobically. Villanova, PA (1980).
4. Shepard, M. C., Lunceford, C. D. Serological typing ofUreaplasma urealyticum isolates from urethritis patients by an agar growth inhibition method. J. Clin. Microbiol. 8 (1978) 566–574.
5. Bushby, S. R. M. Trimethoprim-sulfamethoxazole:In vitro microbiological aspects. J. Infect. Dis. 128 (1973) 442–462.